secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001213900-23-069538
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed amends Scilex stock purchase deal; extends deadline, reduces warrants, adds Junior DIP Compromise
--------------------------------------------------------------------------------

- Second Amendment extends Sale Order deadline to Aug 25, 2023; reduces Scilex warrants from ~1.39M to 693K public and from ~3.1M to 1.55M private.
- Adds condition that Sale Order must include Junior DIP Compromise, treating Sorrento's recovery identical to general unsecured creditors.
- Purchase price remains $105M (credit bid under Replacement DIP Facility and cash). Oramed named successful bidder in auction on Aug 17.
- Transaction subject to Bankruptcy Court approval; hearing scheduled Aug 25, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023069538/0001213900-23-069538-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023069538/ea183972-8k_oramedpharm.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-069538

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer